BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $98.00K in the quarter ending September 30, 2025, a decrease of -54.21%. This brings the company's revenue in the last twelve months to $752.00K, down -66.96% year-over-year. In the year 2024, BioXcel Therapeutics had annual revenue of $2.27M with 64.20% growth.

• Revenue (ttm): $752.00K
• Revenue Growth: -66.96%
• P/S Ratio: 42.75
• Revenue / Employee: $20,324
• Employees: 37
• Market Cap: 31.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.27M	886.00K	64.20%
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-